- What’s New at FDA: Breakthrough Therapy and other Expedited Approval Pathways
- Expanded Access & Patient-Focused Drug Development
- Opportunities & Challenges in Global Oncology Drug Development
So the main topic will be how to accelerate drug approval and how to ensure patients can access new drugs faster- and as we all know, this is something that would make all the difference for patients with cancers like Melanoma!
We'll be a group of European cancer advocates going, so these are problems we share with other cancers.
If you've got questions you would like me to ask, let me know!